Kyowa Kirin Hong Kong
Kyowa Kirin Hong Kong strives to contribute to the health and well-being of people in Hong Kong and Macau by creating new value through the pursuit of advances in life sciences and technologies.
Kyowa Kirin Hong Kong was established in 1993. Since our beginnings to the year 2002, we have focused on sales and marketing functions in Mainland China. From 2003, we commenced sales activities in Hong Kong and Macau.
As part of the Kyowa Kirin Group headquartered in Japan, we are dedicated to pursuing our Commitment to Life as an integral part of our work. Over the years, Kyowa Kirin has invested in our efforts to use innovation and technological advances to further enhance the patient experience and patient value in the lesser-known therapeutic areas.
Kyowa Kirin will realize the successful creation and delivery of life-changing value that ultimately make people smile, as a Japan-based Global Specialty Pharmaceutical company built on the diverse team of experts with shared passion for innovation.
We are focused on developing medicines for diseases where there is a clear patient need for new options. We make full use of multiple therapeutic modalities, including biotechnology such as antibody technology, and beyond, building on our Kyowa Kirin established strengths.
We will meet the needs of patients and society by providing value across the entire patient care pathway, delivering cutting-edge science and technology, grounded in our in-depth pharmaceutical knowledge and expertise.
We pursue world-class product quality and operational excellence to grow our business in ways which build long-term trust with our stakeholders.
Kyowa Kirin Hong Kong aspires to collaborate with our counterparts to contribute to the health and well-being of people around the world by creating new value through the pursuits of advances in life sciences and technologies.